Results 121 to 130 of about 807,190 (203)

Single-nucleotide variant profiling in liquid biopsy with RECO-Cas. [PDF]

Sci Adv
Guo C, Zhang S, Yerramsetti R, Zhang J, Guan X, Yang R, Hou C, Pei M, Schalper KT, Liu X, Li Z, Perpetua L, Gan W, Ibrahim O, Clark RA, Liu C.   +15 more
europepmc   +1 more source

Port Authority Trans-Hudson (PATH) Minutes [PDF]

, 2004
Port Authority Trans-Hudson Corporation
core  

A multifunctional switch for label-free CRISPR/Cas12a sensor with self-driven amplification. [PDF]

Synth Syst Biotechnol
Li P, Lei X, Niu X, Tian W, Li Z, Yu S, Zhang P.   +6 more
europepmc   +1 more source

Boosting CRISPR/Cas12a intrinsic RNA detection capability through pseudo hybrid DNA-RNA substrate design. [PDF]

Nucleic Acids Res
Qiao J, Zhang J, Jiang Q, Jin S, He R, Qiao B, Liu Y.   +6 more
europepmc   +1 more source

Port Authority Trans-Hudson (PATH) Minutes [PDF]

, 2006
Port Authority Trans-Hudson Corporation
core  

New Gene Therapy Strategy for β-Thalassemia. [PDF]

Stem Cell Rev Rep
Liang D, Schmidt-Wolf IGH, Pu J.
europepmc   +1 more source

CRISPR-based electrochemiluminescence biosensors: Principles, optimization strategies, and translational challenges - A review of recent progress. [PDF]

Food Chem (Oxf)
Yin X, Fan Z, Tong Z.
europepmc   +1 more source

Regulation of CRISPR trans-cleavage activity by an overhanging activator. [PDF]

Nucleic Acids Res
Yin N, Yu H, Zhang L, Luo F, Wang W, Han X, He Y, Zhang Y, Wu Y, Pu J, Feng T, Yang G, Chen T, Xie G.   +13 more
europepmc   +1 more source

Port Authority Trans-Hudson (PATH) Minutes [PDF]

, 2003
Port Authority Trans-Hudson Corporation
core   +2 more sources